PortfoliosLab logoPortfoliosLab logo
KNSA vs. RSI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KNSA vs. RSI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kiniksa Pharmaceuticals, Ltd. (KNSA) and Rush Street Interactive, Inc. (RSI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KNSA achieves a 16.00% return, which is significantly lower than RSI's 30.83% return.


KNSA

1D
1.98%
1M
-16.96%
YTD
16.00%
6M
17.89%
1Y
64.38%
3Y*
48.51%
5Y*
29.11%
10Y*

RSI

1D
-0.04%
1M
-8.40%
YTD
30.83%
6M
36.15%
1Y
101.91%
3Y*
99.53%
5Y*
14.09%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

KNSA vs. RSI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
KNSA
Kiniksa Pharmaceuticals, Ltd.
16.00%108.54%12.77%17.09%27.27%-33.39%-4.85%
RSI
Rush Street Interactive, Inc.
30.83%41.62%205.57%25.07%-78.24%-23.79%125.05%

Correlation

The correlation between KNSA and RSI is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.00

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Apr 24, 2020

0.23

Over the past year, the correlation between KNSA and RSI has dropped to 0.00 - well below their long-term average of 0.23, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

KNSA:

$3.94B

RSI:

$2.72B

EPS

KNSA:

$0.92

RSI:

$0.54

PE Ratio

KNSA:

51.96

RSI:

47.32

PEG Ratio

KNSA:

0.50

RSI:

0.08

PS Ratio

KNSA:

5.03

RSI:

2.06

PB Ratio

KNSA:

6.51

RSI:

17.07

Total Revenue (TTM)

KNSA:

$754.05M

RSI:

$1.24B

Gross Profit (TTM)

KNSA:

$294.06M

RSI:

$433.41M

EBITDA (TTM)

KNSA:

$101.06M

RSI:

$162.04M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KNSA vs. RSI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KNSA
KNSA Risk / Return Rank: 8383
Overall Rank
KNSA Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
KNSA Sortino Ratio Rank: 8181
Sortino Ratio Rank
KNSA Omega Ratio Rank: 7979
Omega Ratio Rank
KNSA Calmar Ratio Rank: 8383
Calmar Ratio Rank
KNSA Martin Ratio Rank: 8989
Martin Ratio Rank

RSI
RSI Risk / Return Rank: 8585
Overall Rank
RSI Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
RSI Sortino Ratio Rank: 8686
Sortino Ratio Rank
RSI Omega Ratio Rank: 8686
Omega Ratio Rank
RSI Calmar Ratio Rank: 8585
Calmar Ratio Rank
RSI Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KNSA vs. RSI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kiniksa Pharmaceuticals, Ltd. (KNSA) and Rush Street Interactive, Inc. (RSI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KNSARSIDifference
Sharpe ratioReturn per unit of total volatility

-0.51

Sortino ratioReturn per unit of downside risk

-0.48

Omega ratioGain probability vs. loss probability

1.30

1.38

-0.08

Calmar ratioReturn relative to maximum drawdown

3.06

3.48

-0.41

Martin ratioReturn relative to average drawdown

11.39

7.98

+3.41

KNSA vs. RSI - Sharpe Ratio Comparison

The current KNSA Sharpe Ratio is 1.48, which is comparable to the RSI Sharpe Ratio of 1.99. The chart below compares the historical Sharpe Ratios of KNSA and RSI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


KNSARSIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.48

1.99

-0.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.55

0.23

+0.32

Sharpe Ratio (All Time)

Calculated using the full available price history

0.19

0.29

-0.10

Drawdowns

KNSA vs. RSI - Drawdown Comparison

The maximum KNSA drawdown since its inception was -83.06%, smaller than the maximum RSI drawdown of -88.92%. Use the drawdown chart below to compare losses from any high point for KNSA and RSI.


Loading charts...

Drawdown Indicators


KNSARSIDifference

Max Drawdown

Largest peak-to-trough decline

-83.06%

-88.92%

+5.86%

Max Drawdown (1Y)

Largest decline over 1 year

-21.12%

-29.47%

+8.35%

Max Drawdown (3Y)

Largest decline over 3 years

-34.14%

-42.04%

+7.90%

Max Drawdown (5Y)

Largest decline over 5 years

-53.17%

-86.88%

+33.71%

Current Drawdown

Current decline from peak

-19.55%

-12.86%

-6.69%

Average Drawdown

Average peak-to-trough decline

-40.26%

-50.47%

+10.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.67%

12.82%

-7.15%

Volatility

KNSA vs. RSI - Volatility Comparison

The current volatility for Kiniksa Pharmaceuticals, Ltd. (KNSA) is 10.38%, while Rush Street Interactive, Inc. (RSI) has a volatility of 11.19%. This indicates that KNSA experiences smaller price fluctuations and is considered to be less risky than RSI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KNSARSIDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.38%

11.19%

-0.81%

Volatility (6M)

Calculated over the trailing 6-month period

33.56%

32.03%

+1.53%

Volatility (1Y)

Calculated over the trailing 1-year period

43.77%

51.37%

-7.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.49%

61.95%

-8.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.66%

60.66%

+3.00%

Dividends

KNSA vs. RSI - Dividend Comparison

Neither KNSA nor RSI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

KNSA vs. RSI - Financials Comparison

This section allows you to compare key financial metrics between Kiniksa Pharmaceuticals, Ltd. and Rush Street Interactive, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
214.27M
370.36M
(KNSA) Total Revenue
(RSI) Total Revenue
Values in USD except per share items

KNSA vs. RSI - Profitability Comparison

The chart below illustrates the profitability comparison between Kiniksa Pharmaceuticals, Ltd. and Rush Street Interactive, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202220232024202520260
35.7%
Portfolio components
KNSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.

RSI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rush Street Interactive, Inc. reported a gross profit of 132.17M and revenue of 370.36M. Therefore, the gross margin over that period was 35.7%.

KNSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.

RSI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rush Street Interactive, Inc. reported an operating income of 42.78M and revenue of 370.36M, resulting in an operating margin of 11.6%.

KNSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.

RSI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rush Street Interactive, Inc. reported a net income of 26.21M and revenue of 370.36M, resulting in a net margin of 7.1%.


Frequently Asked Questions


KNSA and RSI have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RSI has higher volatility (11.19%) compared to KNSA (10.38%). In terms of maximum drawdown, KNSA dropped -83.06% vs RSI's -88.92%.

RSI currently has the higher Sharpe Ratio (1.99 vs 1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KNSA and RSI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer